SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare - Quaterly Results

29 Oct 2021 Evaluate
Revenue showed a marginal decline at Rs. 20089.00 millions. For the quarter ended September 2021, as compared to corresponding quarter of last year.A radical decline of -97.02% was reported in the net profit of the company for the quarter ended September 2021 to Rs. 141.00  millions from Rs. 4730.00 millions.The company reported a degrowth in operating Profit to 5537.00 millions from 6884.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 20089.00 20569.00 -2.33 41323.00 38528.00 7.25 77904.00 63474.00 22.73
Other Income 694.00 608.00 14.14 991.00 808.00 22.65 789.00 8494.00 -90.71
PBIDT 5537.00 6884.00 -19.57 12010.00 12976.00 -7.44 23980.00 22725.00 5.52
Interest 241.00 149.00 61.74 683.00 348.00 96.26 709.00 2339.00 -69.69
PBDT 2103.00 6735.00 -68.78 8134.00 12628.00 -35.59 21396.00 19866.00 7.70
Depreciation 1192.00 1121.00 6.33 2359.00 2230.00 5.78 4511.00 4289.00 5.18
PBT 911.00 5614.00 -83.77 5775.00 10398.00 -44.46 16885.00 15577.00 8.40
TAX 770.00 884.00 -12.90 1635.00 1686.00 -3.02 2123.00 2041.00 4.02
Deferred Tax 43.00 -111.00 -138.74 58.00 -150.00 -138.67 -910.00 400.00 -327.50
PAT 141.00 4730.00 -97.02 4140.00 8712.00 -52.48 14762.00 13536.00 9.06
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 27.56 33.47 -17.65 29.06 33.68 -13.70 30.78 35.80 -14.02

Zydus Lifesciences Share Price

901.65 10.00 (1.12%)
04-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.10
Dr. Reddys Lab 1287.95
Cipla 1334.85
Zydus Lifesciences 901.65
Lupin 2350.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×